Developments BioResorative’s Chief Scientist named section editor of top-tier Journal of Translational Medicine BioRestorative Therapies (NASDAQ:BTRX) announced that Francisco Silva, the company’s chief scientist and vice president of research and development, has been appointed section editor of the newly launched Regenerative... July 23, 2024